Caerus Us 1 Inc. (dba Citeline): Introducing Citeline's Site

NEW YORK, May 23, 2023 (GLOBE NEWSWIRE) -- With new Food and Drug Administration (FDA) guidance, study sponsors are no longer viewing clinical trial diversity as "nice to have" but as a "must have." Citeline's

Related Keywords

United States , American , Citeline Sitetrove , Dave Laky , Gewinn Nur , Drug Administration , Centers For Medicare Medicaid Services , Sitetrove Diversity Module , Diversity Module , Medicaid Services , African American , General Manager , Caerus , Citeline , Ntroducing , Itetrove , Diversity , Module , Combining , Obust , Linical , Investigator , Bite , Intelligence , Ith , Patient , Demographics , Support , Diversification , Trials ,